REGN

Regeneron Pharmaceuticals Inc
782.99
31.79 (4.23%)

Regeneron Pharmaceuticals Inc. (REGN) Fundamentals

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).
SHARE INFORMATION
Market Cap$ 81,807,133,572
Shares Outstanding108,901,935
Float102,473,165
Percent Float94.1%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 16,071,700,000
Latest Fiscal EPS$ 72.07
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions2,315
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months3,812,074
Institutional Holdings Percent166.2%
Institutional Sold Previous 3 Months6,887,989
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months246,695
Insider Holdings Percent2.1
Insider Sold Previous 3 Months291,487
Insider Shares Owned2,307,996
TRADING INFO
52 Week High$ 779.00
52 Week Low$ 538.01
52 Week High Change$ 20.61
21 Day Moving Average$ 728.1681
21 Day Extended Moving Average$ 735.327
50 Day Moving Average$ 734.4836
50 Day Extended Moving Average$ 730.6521
200 Day Moving Average$ 675.9961
200 Day Extended Moving Average$ 690.1783
10 Day Average Volume622,248
20 Day Average Volume655,799
30 Day Average Volume593,163
50 Day Average Volume620,139
Alpha0.014674
Beta0.2444
Standard Deviation0.095615
R20.019058
7 Day Price Change$ 8.90
7 Day Percent Change1.2%
21 Day Price Change$ 36.63
21 Day Percent Change5.13%
30 Day Price Change$ 29.71
30 Day Percent Change4.12%
Month to Date Price Change$ -7.27
Month to Date Percent Change-0.96%
Quarter to Date Price Change$ 29.71
Quarter to Date Percent Change4.12%
180 Day Price Change$ 176.24
180 Day Percent Change30.65%
200 Day Price Change$ 143.66
200 Day Percent Change23.65%
Year to Date Price Change$ 29.71
Year to Date Percent Change4.12%

Regeneron Pharmaceuticals Inc. (REGN) Key Ratios

PROFITABILITY
EBIT Margin44.4%
EBITDA Margin46.7%
Pre-Tax Profit Margin45.3%
Profit Margin Count35.87%
Gross Margin85.0%
Profit Margin TOT35.87%
INCOME STATEMENTS
Revenue$ 8,758,500,000
Revenue Per Share$ 81.7911
Revenue (3 Years)$ 12.13
Revenue (5 Years)$ 15.13
FINANCIAL STRENGTH
Price to Tangible Book3.90
Total Debt To Equity0.10
Int Coverage108.60
Current Ratio5.40
Leverage Ratio1.30
Quick Ratio4.40
Long Term Debt To Capital0.11
VALUATION MEASURES
PE Ratio16.00
Enterprise Value$ 78,227,066,730
Price to Sales9.1844
Price to Free Cash82.30
PE High Last 5 Years70.20
Price To Book3.90
Price To Cash Flow15.20
PE Low Last 5 Years12.70
Price to Tangible Book3.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.60
Invoice Turnover0.90
Assets Turnover0.20
Return Assets20.92
Return on Equity27.76
Return on Capital24.99

Regeneron Pharmaceuticals Inc. (REGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOLeonard S. Schleifer
Emplyoees10368
Last AuditUQ
CIK0000872589
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
Websitehttps://www.regeneron.com
Facsimile-
Telephone+1 914 847-7000
Emailmanisha.narasimhan@regeneron.com


Your Recent History
NASDAQ
REGN
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.